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A rtic le  a b s tr a c t—Objective: To explore the incidence of depression and anxiety and to m easure quality of life in women 
w ith idiopathic in tracranial hypertension (IIH), a m atched group cross-sectional study was conducted. Women w ith IIH 
(n = 28) were compared with control groups of weight- and age-matched women not diagnosed w ith IIH (n = 30) and w ith 
age-matched women of normal weight (n = 30). Methods: Eighty-eight women completed a questionnaire soliciting health  
information and standardized questionnaires m easuring depression, anxiety, and quality of life. The groups were com­
pared using analysis of variance and x2 tests. Where appropriate, post hoc comparisons were made using Fisher’s test. 
Results: Patients w ith IIH reported a greater num ber of adverse health  problems than  either of the control groups. 
N on-health-related  psychosocial concerns were equally prevalent among the three groups, bu t IIH patients were signifi­
cantly more affected by hardships associated w ith health  problems th an  the other two groups. The patient group also had 
higher levels of depression and anxiety th an  the control groups. These adverse health  conditions were reflected in 
decreased quality of life m easures for the IIH patients. Conclusions: This study supports previous reports th a t link obesity 
and psychosocial difficulties, bu t obesity alone is not the explanation for the higher levels of depression and lower levels of 
quality of life. K ey w o rd s: Idiopathic in tracranial hypertension—Pseudotumor cerebri—Depression—Anxiety—Quality of 
life—Vision loss—Headache—Obesity—Papilledema.
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Idiopathic intracranial hypertension (IIH) is a condi­
tion of increased intracranial pressure without local­
izing signs except for papilledema with normal 
intracranial contents and normal CSF constituents. 
It is seen more frequently in women than men (8:
I)1-2; women are of childbearing age, and 90% of IIH 
patients are obese.3 The most common symptoms are 
visual obscuration and headache.4 The headaches 
present in at least 90% of patients4 are frequently 
refractory to treatment.5 Other symptoms include 
subjective pulsatile tinnitus, shoulder and arm pain, 
and incoordination.4 Cognition is usually normal.6
Papilledema is present in almost all IIH patients 
and can lead to decreased vision and blindness; one 
third in a large series had substantial visual loss 
including loss of visual field.7-8
Treatment has been directed toward preserving 
vision. Medications that reduce intracranial pressure 
such as diuretics like acetazolamide and furosemide 
have some success.8 When vision is threatened, these
individuals may undergo optic nerve sheath decom­
pression910 or lumbar peritoneal shunts1112 to pre­
serve vision. Even with prompt intervention, visual 
loss can occur.10
Although the accurate diagnosis and appropriate 
treatment of IIH are receiving increasing research 
attention, the psychosocial impact of this condition 
has not been studied systematically. We studied the 
psychosocial impact of IIH and compared levels of 
depression, anxiety, and quality of life measures in 
women diagnosed with IIH with a control group of 
women who were not experiencing the symptomatol­
ogy of IIH but matched the IIH women on age and 
weight, and a control group of age-matched women of 
normal weight without IIH.
M e th o d s . S tu d y  design and  subjects. D ata for th is 
study were obtained from questionnaires completed by 
subjects (n = 88). All patients w ith IIH (n = 28) were 
patients a t the John A. Moran Eye Center, the University
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of U tah in Salt Lake City. Patients w ith IIH were re ­
cruited as follows:
1. Introductory letters, Institutional Review Board (IRB) 
consent forms, and questionnaires th a t had been com­
piled for the purposes of dissem inating an IIH inform a­
tional new sle tter and announcing support group 
m eetings were sent to a list of 62 IIH patients. The 
le tter described the study and encouraged participation 
by all, not ju s t those considerably affected by the condi­
tion (“We very much need your input . . .  no m atter how 
much or how little you are being affected by it. We need 
to find out the range of impact th a t it has on people’s 
lives.”) Twenty completed packets were returned, for a 
response rate  of 32%.
2. Seven of the 28 patien ts (25%) signed IRB consent 
forms and completed questionnaires a t an IIH support 
group meeting.
3. One patien t had begun treatm en t elsewhere and com­
pleted her packet a t the time of admission to the Moran 
Eye Center clinic. Patien t charts were reviewed by a 
neuro-ophthalmologist to assure th a t all patients met 
the modified Dandy Criteria for IIH8—namely, th a t all 
patients had papilledema, normal imaging studies, and 
elevated opening pressure on CSF examination, with 
normal CSF constituents.
Controls not diagnosed w ith IIH, but m atched by age 
and weight to the IIH group, were recruited using flyers 
distributed around the University of U tah’s H ealth Sci­
ences Center. A small compensation ($10) was offered for 
participation. Interested participants were asked to tele­
phone the study center to ascertain age and weight eligibility 
and, if appropriate, were given appointments to sign the IRB 
consent form and complete the questionnaires.
Non-IIH, norm al weight controls (n = 30) were re ­
cruited a t the University of U tah’s H ealth Sciences Center. 
They were matched by age to the IIH group, and their 
“normal weight” was determ ined using Body Mass Index 
(BMI) tables.13 BMI = weight (kilograms)Zheight (meters).2 
All patients in this group had heights and weights th a t 
classified them  into the “acceptable weight” range.13
Measures. Four m easures, one w ritten  for this study 
and three standardized m easures, were used.
A checklist history questionnaire was created using 
“yes” and “no” and listing questions to elicit general infor­
m ation on demographics, general health , m edications, 
hardships currently experienced, and coping. The ques­
tionnaire completed by IIH patients contained questions 
specific to IIH, whereas the controls completed question­
naires w ith sim ilar questions, but th a t did not include 
specific questions regarding IIH.
Depression was m easured using the Beck Depression 
Inventory (BDI),14 a widely used instrum ent for assessing 
the intensity  of depression. The BDI is a 21-item in stru ­
m ent th a t consolidates 21 symptoms and attitudes associ­
ated w ith depression. The questions are rated  on a 4-point 
scale so th a t scores range from 0 to 63. Scoring guidelines 
classify ranges as: 0 to 9 = minimal depression; 10 to 16 = 
mild depression; 17 to 29 = moderate depression; and 30 to 
63 = severe depression.
In addition to querying about anxiety in the general 
questionnaire, anxiety w as m easured using the Spiel- 
berger State-Trait Anxiety Inventory (STAI),le an in stru ­
m ent widely used in clinical practice and in research. The
STAI is a 40-item instrum ent th a t m easures both state 
anxiety, feelings of fear, or worry felt a t the time of the 
testing (20 items) and tra it anxiety, the more stable gener­
ally experienced feelings of fear or worry (20 items). The 20 
item s are rated on a 4-point intensity scale from 1 to 4, 
from “not a t all” to “very much so” for state anxiety, and 
from “almost never” to “almost always” for tra it anxiety. 
Anxiety scores can range from a minimum of 40 to a max­
imum of 80. Extensive data for normative samples have 
been collected, and reported m ean scores for working-age 
women are 34.79 (SD, 9.22) for tra it anxiety and 35.20 
(SD, 10.61) for state anxiety.16
Quality of life was m easured using the SF-36 Health 
Survey,16 a psychometrically sound instrum ent developed 
during the Medical Outcomes Study17 and widely used in 
assessing physical health  as it contributes to overall qual­
ity of life. The SF-36 m easures the impact of health  on 
functioning across eight concepts: physical functioning (the 
extent to which health  lim its physical activities); role func­
tioning (the extent to which health  lim its work and daily 
activities); bodily pain; general health  (as perceived by the 
individual); vitality (energy and pep); social functioning 
(the extent to which health  interferes w ith social activi­
ties); role functioning— emotional (the extent to which 
emotional health  interferes w ith daily functioning); and 
m ental health. Scores are derived from Likert scale re­
sponses to the 36 items, w ith higher scores suggesting 
more positive quality of life. A single-item m easure of per­
ceived health  change is also included bu t is not used to 
score any of the eight m ulti-item  scales.
Analyses. D ata elicited from the general checklist 
questionnaires were tabulated to yield frequency distribu­
tions. Tests of association were used to determine w hether 
p atterns of symptoms associated w ith IIH were different 
from patterns associated w ith obesity. Data derived from 
the three standardized questionnaires completed by the 
three groups were compared using analysis of variance 
(ANOVA) and x2 tests. Post hoc ANOVAs were done after 
elim inating  the four IIH p a tien ts  w ith  notable self­
reported concurrent illnesses, including chronic fatigue 
syndrome, postpolio, and mononucleosis, to test for the 
influence of those illnesses. Post hoc Scheffe F tests were 
conducted for pairwise comparisons.
R e su lts . Demographics. The three groups were equated 
for age, and the IIH patient group and weight-matched 
control group were equated for BMI. The normal weight 
controls reported more years of education than  the IIH 
patients bu t did not differ from the weight-matched con­
trols (table 1). The three groups did not differ w ith regard 
to m arital s ta tus (x2 = 6.11; p = 0.416). Of the 88 patients 
in the study, 38.6% (34/88) were single, 52.2% (46/88) were 
m arried, 7.8% (7/88) were divorced, and 1.1% (1/88) was 
widowed. Patients had the diagnosis of IIH from 0 months 
to 17 years, w ith a m ean of 4.6 years (SD = 4.2 years).
H ealth complaints. Compared w ith the nonpatien t 
groups, a greater percentage of the IIH patients reported 
current headaches, changes in hearing, fatigue, edema, 
vision loss, and sleep problems (all p  <  0.01) (figure 1). 
Additionally, changes in hearing were acknowledged by 13 
of 28 (46.4%) of the IIH patients, 7 of 30 (23.3%) of the 
weight-matched controls, and only 1 of 30 (3.3%) of the 
normal weight controls. Edema was reported a problem for 
16 of 28 (57%) IIH patien ts, 5 of 30 (16.7%) weight-
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T ab le  1 Demographics, mean (SD)




controls F p  Value
Age, y 33.36 (7.04) 32.4(6.42) 31.2 (6.33) 0.754 0.4738
Body m ass index, kg/m2 37.42 (7.39) 34.57 (9.48) 21.6(1.79) 42.59 0.0001*
Education, y 13.75 (2.41) 14.7(1.9) 15.6(1.9) 4.43 0.0136
* Pairwise comparisons using Fisher’s tes t indicated idiopathic in tracran ial hypertension (IIH) patients significantly greater than  
norm al weight controls (p <  0.05), weight controls significantly greater th an  norm al weight controls (p  < 0.05), and no difference 
between IIH  patients and weight controls.
m atched controls, and 2 of 30 (6.7%) normal weight con­
trols. Sleep difficulties were reported by 17 of 28 (60.7%) of 
IIH patients, 14 of 30 (46.7%) of the weight-matched con­
trols, and only 3 of 30 (10%) of the normal weight controls.
Similarly, IIH patients reported other concurrent ill­
nesses including polycystic ovary disease (4/28, 13%), 
chronic fatigue (2/28, 6%), asthm a (2/28, 6%) hypertension 
(2/28, 6%% and digestive abnormalities, mononucleosis, or­
thostatic edema, back problems, postpolio, a rth ritis, de­
pression, and glaucoma (one each, 3%). W eight control 
pa tien ts  reported  polycystic ovary disease (1/30, 3%:), 
asthm a (3/30, 10%}., hypertension (1/30, 3%% digestive ab­
norm alities (2/30, 7%), depression (5/30, 17%), endometrio­
sis (2/30, 7%), arth ritis  (2/30, 7 % \  thyroid abnormalities 
(2/30 7%), glaucoma, and epilepsy. Normal weight control 
patients reported fewer concurrent illnesses, including thy­
roid disorder (1/30, 10%), digestive problems (1/30, 10%), 
and obsessive-compulsive disorder (1/30, 10%).
M edications. Fifteen of the 28 IIH patients (53.6%) 
were currently using diuretics in active trea tm en t of their 
increased pressure; of these, 13 (81%) were taking acet- 
azolamide (Diamox, ESI Lederle Generics, Philadelphia, 
PA), and 2 (12S>) were taking furosemide (Lasix, Hoechst 
M arion Roussel, Kansas City, MO). Forty-three percent 
(12/28) were taking antidepressants for the treatm en t of 
depression or headache. O ther medications included 17 of 
28 (61®  using headache therapy  (nonsteroidal a n ti­
inflammatory, beta-blocker, calcium channel blocker, acute 
headache medication [isometheptene compound (Midrin, 
Carnrick Labs, Cedar Knolls, NJ), sum atrip tan , and oth­
ers]); 1 of 28 (3%) was using b irth  control pills; 3 of 28 
(10%) reported vitam in use. O ther medications included
antihistam ines, thyroid medication, antibiotics, and w arfa­
rin; almost all patients (27/28; 96%) were taking some form 
of medication (table 2).
None of the weight-matched controls reported using di­
uretics. Seven of 30 (23%) reported antidepressant use; 4 
of 30 (13%) reported b irth  control use; 4 of 30 (13%) re­
ported using medications for weight loss (fenfluramine and 
phenterm ine). O ther medications reported included 2 of 30 
(7%) using lorazepam, omeprazole (Prilosec, A stra Merck, 
Wayne, PA); 4 of 30 (13%) using doxycycline, iron, aspirin, 
thyroid medication, m ultiple vitam ins, and lam otrigine 
(Lamictyl, GlaxoWellcome, Research Triangle Park, NC); 
13 of 30 (43%) reported using no medications. Of the nor­
mal weight controls, none were taking diuretics; 3 of 30 
(10%) were using antidepressants; b irth  control pill use 
occurred in 10 of 30 (33%); 3 of 30 (10%) were taking 
vitamins; other medications reported included Synthroid 
(Knoll Pharmaceuticals, Mt. Olive, NJ) (2/30, 7%), antihista­
mines (3/30, 10%), and nonsteroidal anti-inflammatory (1/30, 
3%). Thirteen of 30 (43%) reported using no medication.
Coping. IIH patients were asked how IIH had changed 
their lives both positively and negatively. The open-ended 
question elicited answers th a t included: “learned to accept 
help,” “m et m any wonderful people,” “slow'ed me down 
when overworked,” “m et new friends,” “have become more 
assertive,” [have found that] “I’m not alone,” “support of 
family and friends and co-workers’ in terest,” “have gotten 
more involved w ith my own health  care,” “incentive to lose 
weight,” “realization of how' precious life/vision are,” “made 
me aware of the value of vision,” and “compassion for oth­
ers.” Three of the 28 IIH patients replied, “There are no 
positives w ith IIH,” and 11 of the 28 did not respond.
Figure 1. H ealth  com plaints as m ea­
sured by general questionnaire. A n x i­
ety, the a ttitudes o f  others, and  
financia l pressures were the only 
problem s reported equally often 
am ong the three groups  ( p  >  0.05). 
For a ll other m easures, p a tien ts  w ith  
idiopathic in tracrania l hypertension  
(hatched bars) reported greater h a rd ­
sh ip  than  d id  w eight controls (dark 
bars) a n d  norm al w eight controls 
(checkered bars) ( p <  0.05).
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T a b le  2  Medication use
Drug IIH Weight control Normal weight control
A ntidepressants 12 8 3
Diuretics 15 0 0
Thyroid 1 4 2
BCP/hormones 2 4 11
P ain  medicine 15 2 1
Antihypertensive 4 1 0




Obesity drugs 0 4 0
GI drugs 0 4 0
Allergy 0 1 1
Asthm a 1 0 1
Other 1 2 0
IIH = idiopathic intracranial hypertension; BCP = birth control 
pills; GI = gastrointestinal.
The final question on the general health  questionnaire 
asked, “In coping w ith this condition, w hat has helped 
you?” The IIH patients responded as follows: family—20/ 
30; friends—17/28; doctors—19/28; exercise—7/28; others 
w ith IIH—10/28; getting information about IIH—18/28; re­
laxation techniques—5/28; staying busy—17/28.
Depression/anxiety. According to responses on the 
BDI,14 IIH patients were significantly more depressed than  
normal weight controls (p  <  0.002). The IIH patients also 
scored higher on sta te  and tra it anxiety than  the normal 
weight controls (p  <  0.015). The tendency toward higher 
scores for depression and anxiety in IIH patients compared 
w ith weight-matched controls was not statistically reliable 
(table 3). Although the BDI showed no statistically signifi­
cant difference in depression between IIH and obese con­
trols, IIH patients were in different clinical categories of 
depression (“mild depression” for weight-matched controls 
w ith a mean score of 13.9 versus “moderate depression” for 
IIH patients w ith a m ean score of 17.3).
Health-related quality o f life. Responses to the items 
on the SF-36 H ealth Survey were compiled using standard 
procedures16 to obtain overall scores for each of the sub­
scales (figure 2). For the subscales of physical function, 
role physical, bodily pain, and general health, IIH patients
Table 3 Depression and anxiety, mean (SD)
reported significantly less healthy levels of function than  
weight-matched controls, and both groups reported signifi­
cantly less healthy levels of function th an  the normal 
weight controls (p  <  0.0001). For vitality, m ental health, 
and role emotional, the IIH patients and weight-matched 
controls did not differ from each other, bu t both reported 
significantly lower levels of function th an  the norm al 
weight controls (p  <  0.004). Lower social functioning 
scores differentiated the IIH patients from both of the con­
trol groups, which were not different from each other (p  < 
0 .002).
Information obtained from the SF-36 included a self­
report item  related to current health  as compared w ith 1 
year ago. IIH patients and weight-matched controls were 
significantly more likely to indicate th a t the ir general 
health  had declined. However, IIH patients were more 
likely th an  weight-matched controls to indicate th a t their 
health  was “much” worse th an  a year ago (x2 = 20.28; p  <
0 .01).
D is c u s s io n . The IIH patients reported here are 
similar in age as reported in the literature.3-4 IIH 
patients reported similar symptoms as IIH patients 
in the literature.3-4-17-18 Also, as expected, these symp­
toms were more frequent in IIH patients than either 
weight-matched or normal-weight controls.
We examined whether the greater prevalence of 
concurrent illnesses in the IIH group influenced the 
outcomes related to depression, anxiety, and quality 
of life. We reanalyzed the quality of life data, omit­
ting the four sickest IIH individuals (with diagnoses 
that could affect daily functioning, i.e., chronic fa­
tigue, postpolio, and mononucleosis), and there was 
no significant change in results. This would suggest 
that other concomitant illnesses are not substan­
tially distorting these data.
Similarly, because 78.6% (22/28) of our IIH sam­
ple reported headaches, could simply the experience 
of headache affect quality of life? Previous studies 
examining quality of life in patients with migraine19 
and other headache types20-21 reported a significant 
impact on quality of life in the concepts of role phys­
ical and bodily pain. Across the remaining concepts, 
Santanello et al.19 found that migrainers had compa­
rable scores to the general population. On the other 
hand, patients with IIH in our study scored signifi­
cantly lower in all concepts than the normal-weight




controls F p  Value
BDI Depression 17.61(13.2) 13.9(10.2) 7.6 (6.9) 6.75 0.0019
State Anxiety 46.79(16.06) 41.4(15.4) 33.6(11.0) 6.29 0.0028
T rait Anxiety 48.04 (14.59) 43.8(12.9) 37.0(11.9) 5.15 0.0078
Pairwise comparisons (Fisher’s test) indicated th a t idiopathic in tracranial hypertension (IIH) patients were significantly more 
depressed th an  norm al weight controls (p <  0.05). The IIH  patients also had  higher state and tra it anxiety th an  the norm al weight 
controls (p <  0.05). In  both cases, however, the tendency tow ard higher scores for IIH  patients compared w ith weight controls was not 
statistically reliable.
BDI = Beck Depression Inventory.
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Physical Function Role Physical Bodily Pain General Health Vitality Social Functioning Mental Health Role Emotional
P<.0001 P<.0001 P<.0001 P<.0001 P<.0001 P=.0005 P=.0039 P=,0083
Figure 2. SF-36 health suj'vey o f quality o f life. Pairwise comparisons (Fisher’s test) indicated that idiopathic intracra­
nial hypertension patients (hatched bars) d id  not differ from weight controls (dark bars) f  p >  0.05) on measures o f vital­
ity, mental health, and role emotional. Weight control patients d id  not differ from normal weight controls (checkered 
bars) with regard to social functioning ( p >  0.05). For all other measures, the three groups were significantly different 
from each other for all possible comparisons ( p <  0.05).
controls or migrainers, leading us to conclude that 
headache alone is not accounting for the lower scores 
across quality of life concepts.
Fatigue was more commonly experienced in IIH 
patients than previously reported in the literature, 
and future research should study whether medica­
tion prescribed for IIH patients may influence the 
severity of fatigue. Current or past sleep difficulties 
were reported by 23 (82%) of IIH patients, signifi­
cantly more than both control groups.
Although the three groups did not differ in atti­
tudes of others or financial pressures, IIH patients 
were affected by hardships of headache, fatigue, 
medical testing, visual loss, medical uncertainty, and 
depression. It is interesting to note that in the gen­
eral questionnaire all three groups self-reported anx­
iety; however, when the Spielberger State Trait 
Anxiety Inventory15 was administered, the IIH pa­
tients and weight-matched controls were signifi­
cantly more anxious than the normal weight 
controls.
The fact that IIH patients have poorer physical 
function, poorer general health, more pain, and less 
ability to meet daily demands than weight-matched 
controls or normal-weight controls suggests that obe­
sity alone is not the explanation for these difficulties.
Depression was more common in IIH patients and
weight-matched controls, as shown by the BDI and 
the SF-36 subscales of mental health, role emotional, 
and vitality. Both of these groups were significantly 
different from the normal weight controls. Although 
significant statistical differences between IIH pa­
tients and weight-matched controls were not found, 
the mean scores placed these two groups in different 
ranges of depression—moderate for the IIH patients 
and mild for the weight-matched controls. These 
findings support previous reports in the literature that 
obesity and depression are frequently seen together.22
Medication use was different in all three groups. 
IIH patients tended in general to be taking more 
medications for both increased pressure and head­
ache. Less than half (13/30, 43%) were taking acet- 
azolamide; therefore, the use of this agent alone 
cannot explain the patients’ fatigue levels. In addi­
tion, although both weight-matched controls and IIH 
patients more often tested positive for depression 
than normal weight controls, IIH patients tended to 
be treated more frequently for depression (12 IIH 
patients were taking antidepressants versus seven 
weight-matched patients).
Limitations of the study include selection bias of 
patients from a tertiary care center and patients who 
were at various stages in their disease process. Al­
though the questionnaires measuring depression,
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anxiety, and quality of life are standardized, they are 
based on self-report and therefore may reflect the 
biases of the patients.
The use of medication alone may affect the quality 
of life of our IIH patients. Conversely, perhaps 
the use of many medications relates to the severity 
of symptoms and concurrent problems associated 
with IIH.
Although research packets were mailed to the four 
men and 58 women on the IIH mailing list, only one 
man responded, and his data were not included in 
the study. One would assume that men also would 
have quality of life issues, but this study may not be 
generalizable to men.
This study focused on quality of life issues related 
to a condition that thus far has been investigated 
solely from the medical/physiologic perspective. Re­
cently, there has been heightened awareness and ac­
ceptance of quality of life as a critical outcome of 
medical treatment. Results from this study reinforce 
the psychosocial issues in women with IIH. Quality 
of life issues should be explored and assessed as part 
of the diagnostic process. Medications should be 
carefully selected with awareness of frequent multi­
ple concurrent problems. The fact that so many of 
the IIH patients in this study cited social support 
(family, friends, doctors, accessing information) as 
being of help in coping with IIH is an important 
finding.
As research continues seeking the causes and 
remedies of IIH, concurrent study is needed explor­
ing treatments that may enhance quality of life for 
these patients. What is the quality of life in un­
treated patients? Does quality of life improve over 
time? Does it improve with treatment, including 
weight loss? Does it improve with treatment of 
depression?
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